Testing effectiveness (Phase 2)Study completedNCT02716675
What this trial is testing
Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 2,699